[Primary research on arsenic trioxide inhibiting human breast cancer cells growth and its mechanisms].
The study was to research the biological effect and mechanisms of arsenic trioxide (As2O3) on human breast cancer cell line MDA-MB-231. The cytotoxicity was observed by MTT assay. Apoptosis was detected with Annexin V-FITC + PI dual parameter. Cell cycle and positive rate of proliferation cell nuclear antigen (PCNA), apoptosis associated protein Fas and bcl-2 and intracellular calcium ions (IECa(2+)) levels were measured by flow cytometry. As2O3 could inhibit the growth of MDA-MB-231 cells dramatically. There was obvious dosage-effect correlation (r = 0.99, P < 0.01), its half inhibitory concentration (IC(50)) was 6.65 micromol/L. Apoptosis was observed in MDA-MB-231 cells treated with As2O3. As2O3 could increase Fas expression and IECa(2+) levels and decrease PCNA expression in MDA-MB-231 cells (P < 0.01). Cell cycle was arrested in S + G(2)/M phase, but bcl-2 protein expression were not affected (P > 0.05). As2O3 could inhibit the growth of MDA-MB-231 cells dramatically and induce apoptosis. We proposed that its mechanisms were probably associated with the improved Fas expression and IECa(2+) levels and decreased PCNA expression and cell cycle arrest.